Literature DB >> 3031177

Granulocyte colony-stimulating factor and differentiation-induction in myeloid leukemic cells.

N A Nicola.   

Abstract

The granulocyte colony-stimulating factor (G-CSF) belongs to a family of hemopoietic growth factors regulating the production of granulocytes and macrophages. Murine G-CSF stimulates the proliferation and differentiation of precursors of neutrophilic granulocytes and is also able to stimulate the functional activities of mature neutrophils. Among the hemopoietic growth factors, G-CSF has an outstanding capacity to induce terminal differentiation and suppression of self-renewal in myeloid leukemic cells. Murine and human G-CSF's show complete biological cross-reactivity across species and bind equally well to G-CSF receptors of either species. Specific receptors for G-CSF exist on all normal neutrophilic cells and have not been lost in the generation of primary human myeloid leukemias. This data indicates that G-CSF may be a useful reagent in the treatment of myeloid leukemia, in hemopoietic regeneration and in increasing resistance against infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031177     DOI: 10.1002/stem.5530050102

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  12 in total

Review 1.  Granulocyte colony-stimulating factor for ischemic heart failure: should we use it?

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

2.  Differentiation of the rat myelomonocytic leukemia cell line c-WRT-7 by in vitro culture with the rat bone marrow preadipocyte cell line REC A16.

Authors:  T Tanaka; S Okamura; S Yasumoto; N Takeichi; H Kobayashi; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes.

Authors:  O Elbaz; L M Budel; H Hoogerbrugge; I P Touw; R Delwel; L A Mahmoud; B Löwenberg
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

4.  Hematopoietic growth factor receptors.

Authors:  J H Shieh; M A Moore
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

5.  A Comparative Study of Lung Host Defense in Murine Obesity Models. Insights into Neutrophil Function.

Authors:  Niki D J Ubags; Elianne Burg; Maryellen Antkowiak; Aaron M Wallace; Estee Dilli; Jenna Bement; Matthew J Wargo; Matthew E Poynter; Emiel F M Wouters; Benjamin T Suratt
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

6.  STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.

Authors:  D Small; M Levenstein; E Kim; C Carow; S Amin; P Rockwell; L Witte; C Burrow; M Z Ratajczak; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells.

Authors:  D J Hilton; N A Nicola; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation.

Authors:  F Dong; C van Buitenen; K Pouwels; L H Hoefsloot; B Löwenberg; I P Touw
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

Review 9.  Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors.

Authors:  Reinhard Dummer; Christoph Hoeller; Isabella Pezzani Gruter; Olivier Michielin
Journal:  Cancer Immunol Immunother       Date:  2017-02-25       Impact factor: 6.968

10.  In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients.

Authors:  M H Bronchud; M R Potter; G Morgenstern; M J Blasco; J H Scarffe; N Thatcher; D Crowther; L M Souza; N K Alton; N G Testa
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.